238
Views
4
CrossRef citations to date
0
Altmetric
Reviews

CGRP receptor antagonists: design and screening

(Reader) , (Senior Lecturer) & (Assistant Professor)
Pages 1253-1265 | Published online: 24 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael JM Fischer. (2010) Calcitonin gene-related peptide receptor antagonists for migraine. Expert Opinion on Investigational Drugs 19:7, pages 815-823.
Read now

Articles from other publishers (3)

Yunhao Wang, Genjiang Zheng, Xiaoxing Xie, Wei Yu, Jianxi Wang, Fazhi Zang, Chen Yang, Qiangqiang Xiao, Rongcheng Zhang, Leixin Wei, Xiaodong Wu, Lei Liang, Peng Cao, Chen Xu, Jing Li, Bo Hu, Tao Zhang, Jinglei Wu & Huajiang Chen. (2023) Low-dose celecoxib-loaded PCL fibers reverse intervertebral disc degeneration by up-regulating CHSY3 expression. Journal of Nanobiotechnology 21:1.
Crossref
D.L. Hay, A.C. Conner & D.R. Poyner. 2013. Encyclopedia of Biological Chemistry. Encyclopedia of Biological Chemistry 265 269 .
Feng Xu, Michael Zacuto, Naoki Yoshikawa, Richard Desmond, Scott Hoerrner, Tetsuji Itoh, Michel Journet, Guy R. Humphrey, Cameron Cowden, Neil Strotman & Paul Devine. (2010) Asymmetric Synthesis of Telcagepant, a CGRP Receptor Antagonist for the Treatment of Migraine. The Journal of Organic Chemistry 75:22, pages 7829-7841.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.